FRONTAL/SUBCORTICAL DEMENTIA
Jonathan T. Stewart, MD
REFERENCES
1. Alagiakrishnan K, Lim D, Brahim A, et al. Sexually inappropriate behaviour in
demented elderly people. Postgrad Med J 2005; 81:463-466.
2. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally
segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9:357381.
3. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection.
Sem Neurol 2007; 27:86-92.
4. Archibald SJ, Mateer CA, Kerns KA. Utilization behavior: Clinical manifestations
and neurological mechanisms. Neuropsychol Rev 2001; 11:117-130.
5. Bae H-J, Pandey DK. Treatment of vascular dementia: Evidence from epidemiologic
studies. Curr Treat Opt Cardiovasc Med 2005; 7:219-225.
6. Black B, Muralee S, Tampi RR. Inappropriate sexual behaviors in dementia. J
Geriatr Psychiatry Neurol 2005; 18:155-162.
7. Black S, Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in
vascular dementia: Positive results of a 24-week, multicenter, international,
randomized, placebo-controlled clinical trial. Stroke 2003; 34:2323-2330.
8. Brokate B, Hildebrandt H, Eling P, et al. Frontal lobe dysfunctions in Korsakoff’s
syndrome and chronic alcoholism: Continuity or discontinuity? Neuropsychology
2003; 17:420-428.
9. Chabriat H, Bousser MG. Vascular dementia: potential of antiplatelet agents in
prevention. Eur Neurol 2006; 55:61-69.
10. Clifford DB. AIDS dementia. Med Clin N Am 2002; 86:537-550.
11. Cooper AJ. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in
men suffering from dementia. J Clin Psychiatry 1987; 48:368–370.
12. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;
50:873-880.
13. Cummings JL, Mega MS, Gray K, et al. The Neuropsychiatric Inventory:
Comprehensive assessment of psychopathology in dementia. Neurology 1994;
44:2308-2314.
14. Demaerschalk BM, Wingerchuk DM. Treatment of vascular dementia and vascular
cognitive impairment. Neurologist 2007; 13:37-41.
15. Diehl J, Ernst J, Krapp S, et al. [Misdemeanor in frontotemporal dementia]. Fortschr
Neurol Psychiatr 2006; 74:203-210.
16. Dubois B, Slachevsky A, Litvan I, et al. The FAB: A frontal assessment battery at
bedside. Neurology 2000; 55:1621-1626.
17. Duke LM, Kaszniak AW. Executive control functions in degenerative dementias: A
comparative review. Neuropsychol Rev 2000; 10:75-99.
18. Farlow MR. Use of antidementia agents in vascular dementia: beyond Alzheimer’s
disease. Mayo Clin Proc 2006; 81:1350-1358.
FRONTAL/SUBCORTICAL DEMENTIA
Jonathan T. Stewart, MD
19. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised
double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.
Lancet 1998; 352:1347-1351.
20. Freedman M. Frontotemporal dementia: Recommendations for therapeutic studies,
designs, and approaches. Can J Neurol Sci 2007; 34(Suppl 1):S118-S124.
21. Fritz J, Stewart JT. Resistive aggression in dementia: treatment with lorazepam. Am J
Psychiatry 1990; 147: 1250.
22. Greendyke RM, Kanter DR, Schuster DB, et al. Propranolol treatment of assaultive
patients with organic brain disease: A double-blind crossover, placebo-controlled
study. J Nerv Ment Dis 1986; 174:290-294.
23. Hanon O, Forette F. Prevention of dementia: Lessons from SYST-EUR and
PROGRESS. J Neurol Sci 2004; 226:71-74.
24. Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000;
356:1627-1631.
25. Kahokehr A, Siegert RJ, Weatherall M. The frequency of executive cognitive
impairment in elderly rehabilitation inpatients. J Geriatr Psychiatry Neurol 2004;
17:68-72.
26. Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: Diagnostic criteria for
frontal lobe dementia. Can J Neurol Sci 1997; 24:29-36.
27. Kertesz A, Munoz DG. Frontotemporal dementia. Med Clin N Am 2002; 86:501518.
28. Levy ML, Miller BL, Cummings JL, et al. Alzheimer disease and frontotemporal
dementias. Behavioral distinctions. Arch Neurol 1996; 53:687–690.
29. Light SA, Holroyd S. The use of medroxyprogesterone acetate for the treatment of
sexually inappropriate behaviour in patients with dementia. J Psychiatry Neurosci
2006; 31:132-134.
30. Litvan I. Therapy and management of frontal lobe dementia patients. Neurology
2001; 56(Suppl 4):S41-S45.
31. Mariani C, Defendi S, Mailland E, et al. Frontotemporal dementia. Neurol Sci 2006;
27:S35-S36.
32. Marin RS, Fogel BS, Hawkins J, et al. Apathy: A treatable syndrome. J
Neuropsychiatry Clin Neurosci 1995; 7:23-30.
33. Martin PR, Singleton CK, Hiller-Sturmhofel S. The role of thiamine deficiency in
alcoholic brain disease. Alcohol Res Health 2003; 27:134-142.
34. Mesulam M-M. Frontal cortex and behavior. Ann Neurol 1986; 19:320–325.
35. Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin
therapy in multi-infarct dementia. J Am Geriatr Soc 1989; 37:549-555.
36. Milan G, Iavarone A, Lore E, et al. When behavioral assessment detects
frontotemporal dementia and cognitive testing does not: data from the Frontal
Behavioral Inventory. Int J Geriatr Psychiatry 2007; 22:266-267.
37. Nadeau SE, Malloy PF, Andrew ME. A crossover trial of bromocriptine in the
treatment of vascular dementia. Ann Neurol 1988; 24:270-272.
38. Nelson M, Reid C, Beilin L, et al. Rationale for a trial of low-dose aspirin for the
primary prevention of major adverse cardiovascular events and vascular dementia in
the elderly: Aspirin in Reducing Events in the Elderly (ASPREE). Drugs Aging
2003; 20:897-903.
2
FRONTAL/SUBCORTICAL DEMENTIA
Jonathan T. Stewart, MD
39. Orgogozo JM, Rigaud AS, Stoffler A, et al. Efficacy and safety of memantine in
patients with mild to moderate vascular dementia: a randomized, placebo-controlled
trial. Stroke 2002; 33:1834-1839.
40. Perry E, Ziabreva I, Perry R, et al. Absence of cholinergic deficits in “pure” vascular
dementia. Neurology 2005; 64:132-133.
41. Perry RJ, Miller BL. Behavior and treatment in frontotemporal dementia. Neurology
2001; 56(Suppl 4):S46-S51.
42. Roman GC. Vascular dementia: Distinguishing characteristics, treatment, and
prevention. J Am Geriatr Soc 2003; 51:S296-S304.
43. Roman GC. Vascular dementia: Advances in nosology, diagnosis, treatment and
prevention. Panminerva Med 2004; 46:207-215.
44. Roman GC. Cholinergic dysfunction in vascular dementia. Curr Psychiatry Rep
2005; 7:18-26.
45. Roth RM, Flashman LA, McAllister TW. Apathy and its treatment. Curr Treat
Options Neurol 2007; 9:363-370.
46. Royall DR, Mahurin RK, Gray K. Bedside assessment of executive cognitive
impairment: The Executive Interview (EXIT). J Am Geriatr Soc 1992; 40:12211226.
47. Schmidt KS, Gallo JL, Ferri C, et al. The neuropsychological profile of alcoholrelated dementia suggests cortical and subcortical pathology. Dementia Geriatr Cogn
Disord 2005; 20:286-291.
48. Shankle WR, Nielson KA, Cotman CW. Low-dose propranolol reduces aggression
and agitation resembling that associated with orbitofrontal dysfunction in elderly
demented patients. Alzheimer Dis Assoc Disord 1995; 9:233-237.
49. Stewart JT. The frontal/subcortical dementias. Geriatrics 2006; 61:23-27.
50. Stewart JT. Psychiatric and behavioral manifestations of vascular dementia. Am J
Geriatr Cardiol 2007; 16:165-170.
51. Stewart JT, Gonzalez-Perez E, Zhu Y, et al. Cognitive predictors of resistiveness in
dementia patients. Am J Geriatr Psychiatry 1999; 7:259-263.
52. Stewart JT, Shin KJ. Paroxetine treatment of sexual disinhibition in dementia. Am J
Psychiatry 1997; 154:1474.
53. Talerico K, Evans L. Responding to safety issues in frontotemporal dementias.
Neurology 2001; 56(Suppl 4):S52-S58.
54. Tohgi H, Abe T, Kimura M, et al. Cerebrospinal fluid acetylcholine and choline in
vascular dementia of Binswanger and multiple small infarct types as compared with
Alzheimer-type dementia. J Neural Transm 1996; 103:1211-1220.
55. van Reekum R, Stuss DT, Ostrander L. Apathy: why care? J Neuropsychiatry Clin
Neurosci 2005; 17:7-19.
56. Victor M. Persistent altered mentation due to ethanol. Neurol Clin 1993; 11:639661.
57. Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: a
randomized, placebo-controlled study. Neurology 2003; 61:479-486.
58. Wilson RK, Williams MA. Normal pressure hydrocephalus. Clin Geriatr Med 2006;
22:935-951.
3